ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

House Democrats Take More Swings At Tobacco Industry

February 17, 1989

NCI “Community Cancer Centers” Program in Development, House Report Reveals.

June 30, 2006

Program Announcement For Clinical Research

February 29, 1980

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000